PanTheryx, Inc.
PanTheryx is a global biotechnology and nutrition company dedicated to improving health through innovative bovine colostrum-based therapeutics and health solutions. As the world's largest producer of bovine colostrum, it develops and commercializes products spanning nutritional interventions to biologics, targeting gastrointestinal and immune health for both humans and animals.
Industries
Nr. of Employees
medium (51-250)
PanTheryx, Inc.
Headquarters: Boulder, Colorado; Production facilities: Phoenix, AZ and Ripon, CA
Patents
Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
US-10611828-B2
View DetailsCompositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
US-9701735-B2
View Details
Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
US-10611828-B2
View DetailsCompositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
US-9701735-B2
View DetailsProducts
DiaResQ
Nutrition-based intervention containing immune factors, micronutrients and macronutrients designed to support intestinal repair and address pediatric infectious diarrhea.
PTM202 (nutrition-based diarrheal treatment)
A nutrition-based intervention derived from bovine colostrum and hen’s eggs containing targeted immunoglobulins against common diarrheal pathogens; tested in randomized double-blind placebo-controlled trials.
ColostrumOne (standardized colostrum ingredient)
Standardized bovine colostrum ingredient developed for use in foods, beverages, supplements and medical nutrition products.
TruBiotics (probiotic formulations)
Probiotic supplement formulations containing clinically studied probiotic strains intended to support digestive and immune health.
Life’s First Naturals (colostrum supplement line)
Direct-to-consumer product line of colostrum-based powders, capsules and chewables formulated for adults and children to support immune and digestive health.
Goodgut / Preliva (polyphenol prebiotic)
Plant-based polyphenol prebiotic ingredient intended to nourish beneficial gut bacteria and support digestive health.
DiaResQ
Nutrition-based intervention containing immune factors, micronutrients and macronutrients designed to support intestinal repair and address pediatric infectious diarrhea.
PTM202 (nutrition-based diarrheal treatment)
A nutrition-based intervention derived from bovine colostrum and hen’s eggs containing targeted immunoglobulins against common diarrheal pathogens; tested in randomized double-blind placebo-controlled trials.
ColostrumOne (standardized colostrum ingredient)
Standardized bovine colostrum ingredient developed for use in foods, beverages, supplements and medical nutrition products.
TruBiotics (probiotic formulations)
Probiotic supplement formulations containing clinically studied probiotic strains intended to support digestive and immune health.
Life’s First Naturals (colostrum supplement line)
Direct-to-consumer product line of colostrum-based powders, capsules and chewables formulated for adults and children to support immune and digestive health.
Goodgut / Preliva (polyphenol prebiotic)
Plant-based polyphenol prebiotic ingredient intended to nourish beneficial gut bacteria and support digestive health.
Services
Supply of standardized bovine colostrum ingredients and contract production services for use in foods, beverages and supplements under supply agreements with partners.
Design, conduct and coordination of randomized and controlled clinical trials and investigator-led studies for pediatric diarrheal interventions and other GI-focused nutritional therapeutics.
Formulation development capabilities to create combined probiotic and colostrum-based products for digestive and immune health.
Programmatic partnerships with NGOs, ministries of health and regional distributors to provide product access, education and donated supplies in low-resource settings.
Comparative laboratory testing of colostrum product bioactivity using in vitro and in vivo models to inform sourcing and quality control processes.
Supply of standardized bovine colostrum ingredients and contract production services for use in foods, beverages and supplements under supply agreements with partners.
Design, conduct and coordination of randomized and controlled clinical trials and investigator-led studies for pediatric diarrheal interventions and other GI-focused nutritional therapeutics.
Formulation development capabilities to create combined probiotic and colostrum-based products for digestive and immune health.
Programmatic partnerships with NGOs, ministries of health and regional distributors to provide product access, education and donated supplies in low-resource settings.
Comparative laboratory testing of colostrum product bioactivity using in vitro and in vivo models to inform sourcing and quality control processes.
Expertise Areas
- Bovine colostrum ingredient development
- Medical nutrition and medical foods for gastrointestinal health
- Clinical trial management for pediatric diarrhea interventions
- Preclinical models for gastrointestinal repair
Key Technologies
- Bovine colostrum extraction and standardization
- In vitro gastrointestinal cell migration and proliferation assays
- In vivo gastric injury animal models
- Bioactivity-based quality control assays
News & Updates
PanTheryx expands its product line with the acquisition of the TruBiotics® brand, including probiotic products for human nutrition.
The company unveils a new 112,000 sq. ft. production facility in Phoenix, AZ, to meet growing global demand for bovine colostrum.
An independent expert panel affirms PanTheryx's bovine colostrum as Generally Recognized As Safe (GRAS) for specific food and beverage uses.
A multi-country supply and licensing agreement with Dr. Reddy’s Laboratories to market DiaResQ in India, Nepal, Russia, and other markets.
A direct-to-consumer product line of premium colostrum health and wellness supplements for all ages.
Leadership changes to support growth and innovation, including the appointment of Wes Parris and David Abramson.
PanTheryx expands its product line with the acquisition of the TruBiotics® brand, including probiotic products for human nutrition.
The company unveils a new 112,000 sq. ft. production facility in Phoenix, AZ, to meet growing global demand for bovine colostrum.
An independent expert panel affirms PanTheryx's bovine colostrum as Generally Recognized As Safe (GRAS) for specific food and beverage uses.
A multi-country supply and licensing agreement with Dr. Reddy’s Laboratories to market DiaResQ in India, Nepal, Russia, and other markets.
A direct-to-consumer product line of premium colostrum health and wellness supplements for all ages.
Leadership changes to support growth and innovation, including the appointment of Wes Parris and David Abramson.